Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Design of therapeutic vaccines: Hepatitis B as an example.
Microb. Biotechnol. 5, 270-282 (2012)
Therapeutic vaccines are currently developed for chronic viral infections, such as human papillomavirus (HPV), human immunodeficiency virus (HIV), herpesvirus and hepatitis B (HBV) and C (HCV) virus infections. As an alternative to antiviral treatment or to support only partially effective therapy a therapeutic vaccine shall activate the patient's immune system to fight and finally control or ideally even eliminate the virus. Whereas the success of prophylactic vaccination is based on rapid neutralization of the invading pathogen by antibodies, virus control and elimination of infected cells require T cells. Therefore, induction of a multi-specific and multifunctional T-cell response against key viral antigens is a paradigm of therapeutic vaccination - besides activation of a humoral immune response to limit virus spread. In this review, we describe options to develop a therapeutic vaccine for chronic viral infections using HBV as a promising example.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
T-CELL RESPONSES; CHRONIC HBV INFECTION; TERM-FOLLOW-UP; VIRUS-INFECTION; SURFACE-ANTIGEN; IMMUNE-RESPONSE; CORE ANTIGEN; COMBINATION THERAPY; LYMPHOCYTE RESPONSE; GERMAN GUIDELINE
ISSN (print) / ISBN
1751-7907
e-ISSN
1751-7915
Zeitschrift
Microbial Biotechnology
Quellenangaben
Band: 5,
Heft: 2,
Seiten: 270-282
Verlag
Wiley
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed